OncoSec Medical Ownership 2024 | Who Owns OncoSec Medical Now?

OverviewChart

Institutional Ownership

13.10%

Insider Ownership

28.01%

Retail Ownership

58.88%

Institutional Holders

22.00

OncoSec Medical Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FNY INVESTMENT ADVISERS, LLC	13.70%	0.31%	105,690	105,690	100.00%	272,000	Mar 31, 2023
VANGUARD GROUP INC	7.45%	-	57,488	57,488	100.00%	148,319,000	Mar 31, 2023
STATE STREET CORP	3.27%	-	25,187	-	-	64,982,000	Mar 31, 2023
SALZHAUER MICHAEL	2.70%	0.05%	20,799	-	-	53,661,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	2.26%	-	17,434	-	-	44,980,000	Mar 31, 2023
LPL FINANCIAL LLC	2.26%	-	17,404	17,404	100.00%	44,902,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.36%	-	10,512	-1,986	-15.89%	27,120,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.25%	-	1,929	1,923	32050.00%	4,977,000	Mar 31, 2023
BLACKROCK INC.	0.18%	-	1,410	1	0.07%	3,637,000	Mar 31, 2023
MORGAN STANLEY	0.01%	-	73	-	-	188,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	46	-	-	119,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-1	-20.00%	10,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-91	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-12,339	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,111	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,883	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,253	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,179	-100.00%	-	Mar 31, 2023
CITIGROUP INC	-	-	-	-13	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-12,987	-100.00%	-	Mar 31, 2023

OncoSec Medical's largest institutional shareholder is FNY INVESTMENT ADVISERS, LLC, holding 13.70% of the company's total share outstanding, currently valued at $272.00K. The top 10 institutional shareholders own together 33.44% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FNY INVESTMENT ADVISERS, LLC	13.70%	0.31%	105,690	105,690	100.00%	272,000	Mar 31, 2023
SALZHAUER MICHAEL	2.70%	0.05%	20,799	-	-	53,661,000	Mar 31, 2023
LPL FINANCIAL LLC	2.26%	-	17,404	17,404	100.00%	44,902,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	2.26%	-	17,434	-	-	44,980,000	Mar 31, 2023
VANGUARD GROUP INC	7.45%	-	57,488	57,488	100.00%	148,319,000	Mar 31, 2023
STATE STREET CORP	3.27%	-	25,187	-	-	64,982,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.36%	-	10,512	-1,986	-15.89%	27,120,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.25%	-	1,929	1,923	32050.00%	4,977,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	46	-	-	119,000	Mar 31, 2023
BLACKROCK INC.	0.18%	-	1,410	1	0.07%	3,637,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-1	-20.00%	10,000	Mar 31, 2023
MORGAN STANLEY	0.01%	-	73	-	-	188,000	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-12,987	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,179	-100.00%	-	Mar 31, 2023
CITIGROUP INC	-	-	-	-13	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,883	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-91	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,253	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,111	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-12,339	-100.00%	-	Mar 31, 2023

The largest OncoSec Medical shareholder by % of total assets is FNY INVESTMENT ADVISERS, LLC. The company owns 105.69K shares of OncoSec Medical (ONCS), representing 0.31% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FNY INVESTMENT ADVISERS, LLC	13.70%	0.31%	105,690	105,690	100.00%	272,000	Mar 31, 2023
VANGUARD GROUP INC	7.45%	-	57,488	57,488	100.00%	148,319,000	Mar 31, 2023
LPL FINANCIAL LLC	2.26%	-	17,404	17,404	100.00%	44,902,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.25%	-	1,929	1,923	32050.00%	4,977,000	Mar 31, 2023
BLACKROCK INC.	0.18%	-	1,410	1	0.07%	3,637,000	Mar 31, 2023
MORGAN STANLEY	0.01%	-	73	-	-	188,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	46	-	-	119,000	Mar 31, 2023
STATE STREET CORP	3.27%	-	25,187	-	-	64,982,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	2.26%	-	17,434	-	-	44,980,000	Mar 31, 2023
SALZHAUER MICHAEL	2.70%	0.05%	20,799	-	-	53,661,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-1	-20.00%	10,000	Mar 31, 2023
CITIGROUP INC	-	-	-	-13	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-91	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,883	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.36%	-	10,512	-1,986	-15.89%	27,120,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,253	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-12,339	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-12,987	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,111	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,179	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, OncoSec Medical's largest institutional buyer is FNY INVESTMENT ADVISERS, LLC. The company purchased 105.69K stocks of ONCS, valued at $272.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,179	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,111	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-12,987	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-12,339	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,253	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.36%	-	10,512	-1,986	-15.89%	27,120,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,883	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-91	-100.00%	-	Mar 31, 2023
CITIGROUP INC	-	-	-	-13	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-1	-20.00%	10,000	Mar 31, 2023
SALZHAUER MICHAEL	2.70%	0.05%	20,799	-	-	53,661,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	2.26%	-	17,434	-	-	44,980,000	Mar 31, 2023
STATE STREET CORP	3.27%	-	25,187	-	-	64,982,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	46	-	-	119,000	Mar 31, 2023
MORGAN STANLEY	0.01%	-	73	-	-	188,000	Mar 31, 2023
BLACKROCK INC.	0.18%	-	1,410	1	0.07%	3,637,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.25%	-	1,929	1,923	32050.00%	4,977,000	Mar 31, 2023
LPL FINANCIAL LLC	2.26%	-	17,404	17,404	100.00%	44,902,000	Mar 31, 2023
VANGUARD GROUP INC	7.45%	-	57,488	57,488	100.00%	148,319,000	Mar 31, 2023
FNY INVESTMENT ADVISERS, LLC	13.70%	0.31%	105,690	105,690	100.00%	272,000	Mar 31, 2023

As of Mar 31 2023, OncoSec Medical's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -24.18K shares of ONCS, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FNY INVESTMENT ADVISERS, LLC	13.70%	0.31%	105,690	105,690	100.00%	272,000	Mar 31, 2023
VANGUARD GROUP INC	7.45%	-	57,488	57,488	100.00%	148,319,000	Mar 31, 2023
LPL FINANCIAL LLC	2.26%	-	17,404	17,404	100.00%	44,902,000	Mar 31, 2023

OncoSec Medical's largest new institutional shareholder by number of shares is FNY INVESTMENT ADVISERS, LLC, purchased 105.69K shares, valued at $272.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,179	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,111	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-12,987	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-12,339	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,253	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,883	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-91	-100.00%	-	Mar 31, 2023
CITIGROUP INC	-	-	-	-13	-100.00%	-	Mar 31, 2023

OncoSec Medical's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -24.18K shares, valued at -, as of undefined.

OncoSec Medical Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
NEXPOINT FUNDS I	0.02%	75,000	-	-	Dec 31, 2023
FIDELITY COMMONWEALTH TRUST	0.01%	42,465	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	708,055	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	222,876	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	19,157	-	-	Mar 31, 2024
AdvisorShares Trust	0.00%	2,160	-	-	Mar 28, 2024
T. Rowe Price Index Trust, Inc.	0.00%	11,400	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	9,259	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,710	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	1,785	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,111	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	2,100	1,900	950.00%	Mar 31, 2021

OncoSec Medical's largest mutual fund holder by % of total assets is "NEXPOINT FUNDS I", owning 75.00K shares, compromising 0.02% of its total assets.

OncoSec Medical Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	22	-4.35%
30 Jun, 22	23	-11.54%
31 Mar, 22	26	-18.75%
31 Dec, 21	32	-8.57%
30 Sep, 21	35	2.94%
30 Jun, 21	34	-
31 Mar, 21	34	9.68%
31 Dec, 20	31	34.78%
30 Sep, 20	23	76.92%
30 Jun, 20	13	-13.33%
31 Mar, 20	15	-16.67%
31 Dec, 19	18	-5.26%
30 Sep, 19	19	11.76%
30 Jun, 19	17	-

As of 30 Sep 22, 22 institutions are holding OncoSec Medical's shares, representing a decrease of -4.35% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	5,150,275	-1.02%
30 Jun, 22	5,203,252	-1.68%
31 Mar, 22	5,292,110	-4.40%
31 Dec, 21	5,535,805	-14.62%
30 Sep, 21	6,483,833	-6.19%
30 Jun, 21	6,911,464	-8.95%
31 Mar, 21	7,590,733	78.41%
31 Dec, 20	4,254,602	266.19%
30 Sep, 20	1,161,856	25.25%
30 Jun, 20	927,650	19.40%
31 Mar, 20	776,958	6.81%
31 Dec, 19	727,428	-5.16%
30 Sep, 19	767,002	23.74%
30 Jun, 19	619,832	-

OncoSec Medical (ONCS) has 5.15M shares outstanding as of 30 Sep 22, down -1.02% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	13.10%	7.48%
30 Jun, 22	13.24%	7.32%
31 Mar, 22	13.45%	6.78%
31 Dec, 21	14.08%	5.14%
30 Sep, 21	16.55%	3.75%
30 Jun, 21	21.01%	5.08%
31 Mar, 21	20.33%	9.24%
31 Dec, 20	14.84%	78.77%
30 Sep, 20	4.34%	36.15%
30 Jun, 20	3.47%	27.66%
31 Mar, 20	3.54%	32.23%
31 Dec, 19	3.31%	27.15%
30 Sep, 19	3.49%	43.83%
30 Jun, 19	2.82%	-

As of 30 Sep 22, OncoSec Medical is held by 13.10% institutional shareholders, representing a 7.48% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	6	50.00%
30 Jun, 22	4	-50.00%
31 Mar, 22	8	-50.00%
31 Dec, 21	16	-30.43%
30 Sep, 21	23	9.52%
30 Jun, 21	21	-22.22%
31 Mar, 21	27	17.39%
31 Dec, 20	23	43.75%
30 Sep, 20	16	100.00%
30 Jun, 20	8	100.00%
31 Mar, 20	4	-33.33%
31 Dec, 19	6	-14.29%
30 Sep, 19	7	-58.82%
30 Jun, 19	17	-

6 institutional shareholders have increased their position in ONCS stock as of 30 Sep 22 compared to 4 in the previous quarter (a 50.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	6	-25.00%
30 Jun, 22	8	-11.11%
31 Mar, 22	9	12.50%
31 Dec, 21	8	14.29%
30 Sep, 21	7	-30.00%
30 Jun, 21	10	150.00%
31 Mar, 21	4	-42.86%
31 Dec, 20	7	133.33%
30 Sep, 20	3	200.00%
30 Jun, 20	1	-75.00%
31 Mar, 20	4	-
31 Dec, 19	4	33.33%
30 Sep, 19	3	-
30 Jun, 19	-	-

6 institutional shareholders have reduced their position in ONCS stock as of 30 Sep 22 compared to 8 in the previous quarter (a -25.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	22	-4.35%	5,150,275	-1.02%	13.10%	7.48%	6	50.00%	6	-25.00%
30 Jun, 22	23	-11.54%	5,203,252	-1.68%	13.24%	7.32%	4	-50.00%	8	-11.11%
31 Mar, 22	26	-18.75%	5,292,110	-4.40%	13.45%	6.78%	8	-50.00%	9	12.50%
31 Dec, 21	32	-8.57%	5,535,805	-14.62%	14.08%	5.14%	16	-30.43%	8	14.29%
30 Sep, 21	35	2.94%	6,483,833	-6.19%	16.55%	3.75%	23	9.52%	7	-30.00%
30 Jun, 21	34	-	6,911,464	-8.95%	21.01%	5.08%	21	-22.22%	10	150.00%
31 Mar, 21	34	9.68%	7,590,733	78.41%	20.33%	9.24%	27	17.39%	4	-42.86%
31 Dec, 20	31	34.78%	4,254,602	266.19%	14.84%	78.77%	23	43.75%	7	133.33%
30 Sep, 20	23	76.92%	1,161,856	25.25%	4.34%	36.15%	16	100.00%	3	200.00%
30 Jun, 20	13	-13.33%	927,650	19.40%	3.47%	27.66%	8	100.00%	1	-75.00%
31 Mar, 20	15	-16.67%	776,958	6.81%	3.54%	32.23%	4	-33.33%	4	-
31 Dec, 19	18	-5.26%	727,428	-5.16%	3.31%	27.15%	6	-14.29%	4	33.33%
30 Sep, 19	19	11.76%	767,002	23.74%	3.49%	43.83%	7	-58.82%	3	-
30 Jun, 19	17	-	619,832	-	2.82%	-	17	-	-	-

OncoSec Medical Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 09, 2023	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	40	$1.37	$54.80	1,008
Nov 04, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	283	$0.37	$104.71	22,975
Aug 05, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	284	$0.71	$201.64	23,258
May 06, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	274	$0.83	$227.42	23,542
Feb 11, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	409	$0.88	$359.92	23,816
Nov 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	343	$1.75	$600.25	24,225
Aug 25, 2021	DALESANDRO MARGARET	director	-	P-Purchase	Buy	20,000	$1.89	$37.80K	20,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	4,000	$1.88	$7.52K	12,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	8,000	$1.94	$15.52K	8,000
Aug 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	412	$2.18	$898.16	24,568
Jun 29, 2021	Leuthner Brian A	officer	Interim CEO	S-Sale	Sell	13,613	$3.16	$43.02K	178,387

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 25, 2021	DALESANDRO MARGARET	director	-	P-Purchase	Buy	20,000	$1.89	$37.80K	20,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	4,000	$1.88	$7.52K	12,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	8,000	$1.94	$15.52K	8,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 09, 2023	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	40	$1.37	$54.80	1,008
Nov 04, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	283	$0.37	$104.71	22,975
Aug 05, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	284	$0.71	$201.64	23,258
May 06, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	274	$0.83	$227.42	23,542
Feb 11, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	409	$0.88	$359.92	23,816
Nov 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	343	$1.75	$600.25	24,225
Aug 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	412	$2.18	$898.16	24,568
Jun 29, 2021	Leuthner Brian A	officer	Interim CEO	S-Sale	Sell	13,613	$3.16	$43.02K	178,387

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 09, 2023	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	40	$1.37	$54.80	1,008
Nov 04, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	283	$0.37	$104.71	22,975
Oct 12, 2022	Foster Spahr Stephany	director	-	A-Award	Buy	50,000	-	-	50,000
Oct 12, 2022	Foster Spahr Stephany	director			Buy	-	-	-	-
Aug 05, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	284	$0.71	$201.64	23,258
May 06, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	274	$0.83	$227.42	23,542
May 03, 2022	Arch Robert H.	officer	President and CEO	A-Award	Buy	700,000	-	-	700,000
May 03, 2022	Arch Robert H.	officer	-		Buy	-	-	-	-
Feb 28, 2022	Chi George	officer	-		Buy	-	-	-	-
Feb 11, 2022	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	409	$0.88	$359.92	23,816
Jan 26, 2022	Shi Lin	director			Buy	-	-	-	-
Nov 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	343	$1.75	$600.25	24,225
Aug 25, 2021	DALESANDRO MARGARET	director	-	P-Purchase	Buy	20,000	$1.89	$37.80K	20,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	4,000	$1.88	$7.52K	12,000
Aug 24, 2021	Zhao Yuhang	director	-	P-Purchase	Buy	8,000	$1.94	$15.52K	8,000
Aug 03, 2021	DelAversano Robert J	officer	VP, Finance	S-Sale	Sell	412	$2.18	$898.16	24,568
Jun 29, 2021	DEMESA JAMES M	director	-	A-Award	Buy	25,000	$3.16	$79.00K	25,000
Jun 29, 2021	DelAversano Robert J	officer	Vice President, Finance	A-Award	Buy	35,000	$3.16	$110.60K	35,000
Jun 29, 2021	Leuthner Brian A	officer	Interim CEO	A-Award	Buy	192,000	-	-	192,000
Jun 29, 2021	Leuthner Brian A	officer	Interim CEO	S-Sale	Sell	13,613	$3.16	$43.02K	178,387

The last insider sell of OncoSec Medical's stock was made by DelAversano Robert J on Feb 09 2023, selling 40 shares at $1.37 per share (valued at $54.80). The last insider buy of ONCS was made by DALESANDRO MARGARET on Aug 25 2021, buying 20,000 shares at $1.89 per share (worth $37.80K).

OncoSec Medical Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	1	-
Q4 2022	1	1	100.00%
Q3 2022	-	1	-
Q2 2022	1	1	100.00%
Q1 2022	-	1	-
Q4 2021	-	1	-
Q3 2021	3	1	300.00%
Q2 2021	13	3	433.33%
Q1 2021	6	1	600.00%
Q4 2020	-	7	-
Q3 2020	10	2	500.00%
Q2 2020	13	4	325.00%
Q1 2020	-	2	-
Q4 2019	-	2	-
Q3 2019	3	2	150.00%
Q2 2019	5	2	250.00%
Q1 2019	6	2	300.00%
Q4 2018	7	3	233.33%
Q3 2018	1	8	12.50%
Q2 2018	11	44	25.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by OncoSec Medical's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	1	-
Q4 2022	-	1	-
Q3 2022	-	1	-
Q2 2022	-	1	-
Q1 2022	-	1	-
Q4 2021	-	1	-
Q3 2021	3	1	300.00%
Q2 2021	2	3	66.67%
Q1 2021	2	1	200.00%
Q4 2020	-	7	-
Q3 2020	2	1	200.00%
Q2 2020	-	1	-
Q1 2020	-	2	-
Q4 2019	-	2	-
Q3 2019	3	-	-
Q2 2019	4	-	-
Q1 2019	-	-	-
Q4 2018	3	-	-
Q3 2018	-	5	-
Q2 2018	-	40	-

As of Q1 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of OncoSec Medical's stocks.

OncoSec Medical Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BDRX	Biodexa Pharmaceuticals Plc
CFRX	ContraFect Corporation
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
FWBI	Entero Therapeutics, Inc.
DRMA	Dermata Therapeutics, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
UNCY	Unicycive Therapeutics, Inc.
ATNF	180 Life Sciences Corp.
PALI	Palisade Bio, Inc.

ONCS Ownership FAQ

Who Owns OncoSec Medical?

OncoSec Medical is owned by institutional shareholders (13.10%), insiders (28.01%), and public (58.88%). The largest institutional shareholder of OncoSec Medical is FNY INVESTMENT ADVISERS, LLC (13.70% of total shares) and the top mutual fund owner is NEXPOINT FUNDS I (0.02% of total shares).

Who are the major institutional shareholders of OncoSec Medical?

OncoSec Medical's major institutional shareholders are FNY INVESTMENT ADVISERS, LLC, VANGUARD GROUP INC, STATE STREET CORP, SALZHAUER MICHAEL, and BANK OF NEW YORK MELLON CORP. The top five shareholders own together 29.37% of the company's share outstanding.

How many OncoSec Medical shareholders are there?

As of Sep 2022, there are 22 institutional shareholders of OncoSec Medical.

What percentage of OncoSec Medical is owned by FNY INVESTMENT ADVISERS, LLC?

FNY INVESTMENT ADVISERS, LLC owns 105.69K shares of OncoSec Medical, representing 13.70% of the company's total shares outstanding, valued at $272K (as of Mar 2023).

What percentage of OncoSec Medical is owned by VANGUARD GROUP INC?

As of Mar 2023, VANGUARD GROUP INC holds 57.49K shares of OncoSec Medical (ONCS), compromising 7.45% of the company, valued at $148.32M.

What percentage of OncoSec Medical is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of OncoSec Medical. The company owns 25.19K of the company's shares outstanding (worth $64.98M).